• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌的骨和钙化软组织转移灶在F-氟化物PET/CT上比在镓-奥曲肽PET/CT上显示得更清晰。

Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on F-Fluoride PET/CT than on Ga-Dotatate PET/CT.

作者信息

Duarte Paulo Schiavom, de Castroneves Luciana Audi, Sado Heitor Naoki, Sapienza Marcelo Tatit, de Oliveira Hoff Ana Amélia Fialho, Buchpiguel Carlos Alberto

机构信息

1Division of Nuclear Medicine, São Paulo Cancer Institute (ICESP), Av. Dr. Arnaldo, 251, 4° SS, Cerqueira César, São Paulo, SP 01246-000 Brazil.

2Division of Endocrinology, São Paulo Cancer Institute (ICESP), São Paulo, Brazil.

出版信息

Nucl Med Mol Imaging. 2018 Aug;52(4):318-323. doi: 10.1007/s13139-018-0527-8. Epub 2018 Jun 4.

DOI:10.1007/s13139-018-0527-8
PMID:30100945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6066486/
Abstract

Herein, we report a case of a 19-year-old man with multiple endocrine neoplasia type 2B (MEN2B) and medullary thyroid carcinoma (MTC) diagnosed when he was 12 years of age. The patient had previously undergone total thyroidectomy, cervical radiotherapy, and chemotherapy. He progressed with known bone, pulmonary, and lymph node metastases and was scanned with F-fluoride (F-NaF) and Ga-dotatate whole-body positron emission tomography/computed tomography (PET/CT) for metastatic disease monitoring. We found that the MTC bone metastases and soft tissue calcified metastases were better characterized on F-NaF PET/CT than on Ga-dotatate PET/CT. This case illustrates that the F-NaF PET/CT could be helpful not only to the detection of bone metastases but also to the detection of calcified soft tissue metastases in patients with MTC.

摘要

在此,我们报告一例19岁男性病例,其在12岁时被诊断为2B型多发性内分泌腺瘤病(MEN2B)和甲状腺髓样癌(MTC)。该患者此前已接受全甲状腺切除术、颈部放疗和化疗。他出现了已知的骨、肺和淋巴结转移,并接受了F - 氟化物(F - NaF)和镓 - 奥曲肽全身正电子发射断层扫描/计算机断层扫描(PET/CT)以监测转移性疾病。我们发现,与镓 - 奥曲肽PET/CT相比,F - NaF PET/CT对MTC骨转移和软组织钙化转移的特征显示更佳。该病例表明,F - NaF PET/CT不仅有助于检测MTC患者的骨转移,还有助于检测钙化的软组织转移。

相似文献

1
Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on F-Fluoride PET/CT than on Ga-Dotatate PET/CT.甲状腺髓样癌的骨和钙化软组织转移灶在F-氟化物PET/CT上比在镓-奥曲肽PET/CT上显示得更清晰。
Nucl Med Mol Imaging. 2018 Aug;52(4):318-323. doi: 10.1007/s13139-018-0527-8. Epub 2018 Jun 4.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.在血清降钙素水平升高的情况下,镓68 DOTATATE PET/CT在检测甲状腺髓样癌方面优于其他成像方式。
Hell J Nucl Med. 2015 Jan-Apr;18(1):19-24. doi: 10.1967/s002449910163. Epub 2015 Feb 13.
4
Comparison of F-NaF PET/CT with Other Imaging Methods in the Detection of Bone Metastases in Patients with Medullary Thyroid Cancer: a Report of a Series of 31 Cases.F-NaF PET/CT与其他成像方法在检测甲状腺髓样癌患者骨转移中的比较:31例系列报告
Nucl Med Mol Imaging. 2020 Dec;54(6):281-291. doi: 10.1007/s13139-020-00666-3. Epub 2020 Sep 28.
5
Clinical impact of Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer.Ga-DOTATATE PET-CT 成像对甲状腺髓样癌患者的临床影响。
Ann Nucl Med. 2020 Sep;34(9):663-674. doi: 10.1007/s12149-020-01494-3. Epub 2020 Jun 29.
6
Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.⁶⁸Ga-DOTATATE PET-CT、¹⁸F-FDG PET-CT与99mTc-(V)DMSA闪烁扫描术在检测复发性或转移性甲状腺髓样癌中的比较
Nucl Med Commun. 2015 Mar;36(3):242-50. doi: 10.1097/MNM.0000000000000240.
7
Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study.促甲状腺激素在放射性碘难治性甲状腺癌68Ga-DOTATATE PET/CT中的作用:一项初步研究。
Nucl Med Commun. 2018 May;39(5):441-450. doi: 10.1097/MNM.0000000000000823.
8
Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with In-octreotide SPECT/CT and conventional imaging.镓-多柔比星PET/CT在复发性甲状腺髓样癌中的应用:与铟-奥曲肽SPECT/CT及传统影像学的逐病灶比较
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1695-1701. doi: 10.1007/s00259-017-3701-9. Epub 2017 Apr 20.
9
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.对于放射性碘难治性分化型甲状腺癌,[(68)Ga] DOTATATE PET/MRI和[(18)F] FDG PET/CT具有互补性,且优于扩散加权磁共振成像。
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1765-72. doi: 10.1007/s00259-016-3378-5. Epub 2016 Apr 8.
10
MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Ga-DOTATATE and F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting.在肽受体放射性核素治疗(PRRT)检查背景下,对镓-多柔比星(Ga-DOTATATE)和氟-氟代脱氧葡萄糖(F-FDG)双示踪剂PET/CT及多模态解剖成像进行MIB-1指数分层评估,用于不明原发灶的转移性神经内分泌肿瘤。
J Nucl Med Technol. 2017 Mar;45(1):34-41. doi: 10.2967/jnmt.116.185777. Epub 2017 Feb 2.

引用本文的文献

1
Holomics and Artificial Intelligence-Driven Precision Oncology for Medullary Thyroid Carcinoma: Addressing Challenges of a Rare and Aggressive Disease.全基因组学与人工智能驱动的甲状腺髓样癌精准肿瘤学:应对一种罕见侵袭性疾病的挑战
Cancers (Basel). 2024 Oct 13;16(20):3469. doi: 10.3390/cancers16203469.
2
Correlation of F-sodium fluoride uptake and radiodensity in extraosseous metastases of medullary thyroid carcinoma.氟[18F]酸钠摄取与髓样甲状腺癌骨外转移灶放射性密度的相关性。
Arch Endocrinol Metab. 2024 Apr 11;68:e230152. doi: 10.20945/2359-4292-2023-0152.
3
Comparison of F-NaF PET/CT with Other Imaging Methods in the Detection of Bone Metastases in Patients with Medullary Thyroid Cancer: a Report of a Series of 31 Cases.F-NaF PET/CT与其他成像方法在检测甲状腺髓样癌患者骨转移中的比较:31例系列报告
Nucl Med Mol Imaging. 2020 Dec;54(6):281-291. doi: 10.1007/s13139-020-00666-3. Epub 2020 Sep 28.
4
Letter to the Editor: F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.致编辑的信:欧洲核医学与分子影像学会(EANM)甲状腺髓样癌PET/CT成像实践指南未引用F-NaF。
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):525-526. doi: 10.1007/s00259-019-04556-5. Epub 2019 Nov 18.

本文引用的文献

1
The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.18F-氟化钠PET/CT骨扫描在乳腺癌和前列腺癌骨转移疾病诊断中的作用
J Nucl Med Technol. 2016 Dec;44(4):217-222. doi: 10.2967/jnmt.116.176859. Epub 2016 Sep 15.
2
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.2015年修订版美国甲状腺协会髓样甲状腺癌管理指南:欧洲核医学协会因核医学作用被“非循证”边缘化而“循证”拒绝认可这些指南。
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1486-90. doi: 10.1007/s00259-016-3404-7. Epub 2016 Apr 27.
3
Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues.使用放射性标记的生长抑素类似物对髓样和非髓样甲状腺癌进行肽受体放射性核素治疗(PRRT)。
Semin Nucl Med. 2016 May;46(3):215-24. doi: 10.1053/j.semnuclmed.2016.01.010.
4
177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT aid in personalized treatment decision making in selecting the best therapeutic option?177镥-奥曲肽与177镥-乙二胺四甲基膦酸对甲状腺髓样癌和神经内分泌肿瘤骨局限性疼痛性转移性疾病的疗效比较及联合/序贯治疗:68镥-奥曲肽和18F-氟化物PET-CT的半定量比较能否有助于在选择最佳治疗方案时做出个性化治疗决策?
Nucl Med Commun. 2016 Jan;37(1):100-2. doi: 10.1097/MNM.0000000000000397.
5
Visualization of Lymph Nodal and Hepatic Metastases of Medullary Thyroid Carcinoma on 18F-Fluoride PET/CT.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对甲状腺髓样癌淋巴结和肝转移的可视化。
Clin Nucl Med. 2015 Nov;40(11):895-6. doi: 10.1097/RLU.0000000000000939.
6
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
7
2012 European thyroid association guidelines for metastatic medullary thyroid cancer.2012 年欧洲甲状腺协会转移性甲状腺髓样癌治疗指南。
Eur Thyroid J. 2012 Apr;1(1):5-14. doi: 10.1159/000336977. Epub 2012 Mar 28.
8
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.比较 18F-DOPA、18F-FDG 和 68Ga-生长抑素类似物 PET/CT 在复发性甲状腺髓样癌患者中的应用。
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):569-80. doi: 10.1007/s00259-011-2031-6. Epub 2012 Jan 6.
9
Extraosseus uptake of F-18 fluoride in the primary malignancy and cerebral metastasis in a case of non-small-cell lung cancer.原发性恶性肿瘤和非小细胞肺癌脑转移中 F-18 氟化物的骨外摄取。
Clin Nucl Med. 2011 Jul;36(7):609-11. doi: 10.1097/RLU.0b013e318217af49.
10
Biomarker-based risk stratification for previously untreated medullary thyroid cancer.基于生物标志物的未经治疗的甲状腺髓样癌风险分层。
J Clin Endocrinol Metab. 2010 Jun;95(6):2655-63. doi: 10.1210/jc.2009-2368. Epub 2010 Mar 25.